Context Therapeutics Announces Amendment To Its Exclusive License Agreement With BioAtla To Remove All Future Milestone And Royalty Obligations For CT-202 In Exchange For A $4.5M Upfront Payment And A Final $2M Payment Due By August 1
Context Therapeutics Inc CNTX
$2.85
▼ -4.36%
($-0.13)
Open
$2.99
Prev Close
$2.98
Day Range
$2.80 – $2.99
52W Range
$0.49 – $3.62
Market Cap
$273.80M
Beta
1.64
EPS (TTM)
$-0.42
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-20 |
| Shares Out. | 91,880,000 |
| Website | contexttherapeutics.com/ ↗ |
| Phone | 12672257416 |
Context Therapeutics Inc is a publicly traded company under the ticker symbol CNTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)